Santarpia L - Search Results

1

Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis.

Planchard D, Besse B, Groen HJM, Hashemi SMS, Mazieres J, Kim TM, Quoix E, Souquet PJ, Barlesi F, Baik C, Villaruz LC, Kelly RJ, Zhang S, Tan M, Gasal E, Santarpia L, Johnson BE. Planchard D, et al. Among authors: santarpia l. J Thorac Oncol. 2022 Jan;17(1):103-115. doi: 10.1016/j.jtho.2021.08.011. Epub 2021 Aug 26. J Thorac Oncol. 2022. PMID: 34455067 Free article. Clinical Trial.

2

Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.

Santarpia L, Myers JN, Sherman SI, Trimarchi F, Clayman GL, El-Naggar AK. Santarpia L, et al. Cancer. 2010 Jun 15;116(12):2974-83. doi: 10.1002/cncr.25061. Cancer. 2010. PMID: 20564403 Free article.

3

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.

Santarpia L, Sherman SI, Marabotti A, Clayman GL, El-Naggar AK. Santarpia L, et al. Hum Pathol. 2009 Jun;40(6):827-33. doi: 10.1016/j.humpath.2008.11.003. Epub 2009 Feb 5. Hum Pathol. 2009. PMID: 19200582

4

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients.

Jung EJ, Santarpia L, Kim J, Esteva FJ, Moretti E, Buzdar AU, Di Leo A, Le XF, Bast RC Jr, Park ST, Pusztai L, Calin GA. Jung EJ, et al. Among authors: santarpia l. Cancer. 2012 May 15;118(10):2603-14. doi: 10.1002/cncr.26565. Epub 2011 Oct 5. Cancer. 2012. PMID: 22370716 Free PMC article.

5

Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification.

Elliott DD, Sherman SI, Busaidy NL, Williams MD, Santarpia L, Clayman GL, El-Naggar AK. Elliott DD, et al. Among authors: santarpia l. Hum Pathol. 2008 Jan;39(1):15-20. doi: 10.1016/j.humpath.2007.05.012. Epub 2007 Oct 18. Hum Pathol. 2008. PMID: 17949783

6

Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.

Santarpia L, El-Naggar AK, Cote GJ, Myers JN, Sherman SI. Santarpia L, et al. J Clin Endocrinol Metab. 2008 Jan;93(1):278-84. doi: 10.1210/jc.2007-1076. Epub 2007 Nov 7. J Clin Endocrinol Metab. 2008. PMID: 17989125

7

Four patients with cutaneous metastases from medullary thyroid cancer.

Santarpia L, El-Naggar AK, Sherman SI, Hymes SR, Gagel RF, Shaw S, Sarlis NJ. Santarpia L, et al. Thyroid. 2008 Aug;18(8):901-5. doi: 10.1089/thy.2007.0179. Thyroid. 2008. PMID: 18651821

8

High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma.

Ye L, Santarpia L, Cote GJ, El-Naggar AK, Gagel RF. Ye L, et al. Among authors: santarpia l. J Clin Endocrinol Metab. 2008 Nov;93(11):4367-72. doi: 10.1210/jc.2008-0912. Epub 2008 Sep 2. J Clin Endocrinol Metab. 2008. PMID: 18765511 Free PMC article.

9

Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy.

Santarpia L, Lippman SM, El-Naggar AK. Santarpia L, et al. Expert Opin Ther Targets. 2012 Jan;16(1):103-19. doi: 10.1517/14728222.2011.645805. Epub 2012 Jan 12. Expert Opin Ther Targets. 2012. PMID: 22239440 Free PMC article. Review.

10

Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer.

Santarpia L, Gagel RF, Sherman SI, Sarlis NJ, Evans DB, Hoff AO. Santarpia L, et al. Head Neck. 2009 Mar;31(3):419-23. doi: 10.1002/hed.20911. Head Neck. 2009. PMID: 18798312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page